Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/11/2003US20030170257 Protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites.
09/11/2003US20030170256 Coding for antigens expressed by tumor cells which may be recognized by cytotoxic T cells, leading to lysis of the tumor that express it.
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170248 Constant region contains a human immunoglobulin and variable region contains a non-human immunoglobulin variable region; especially treating an infection caused by Enterohemorrhagic Escherichia coli
09/11/2003US20030170247 Methods for detection and treatment of neural cancers
09/11/2003US20030170243 Use of human plasma hyaluronidase in cancer treatment
09/11/2003US20030170242 Novel isoforms of vascular endothelial cell growth inhibitor
09/11/2003US20030170234 Combination of the antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin; treating cancer
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170228 Compositions and methods for the treatment of tumor
09/11/2003US20030170222 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
09/11/2003US20030170220 For inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia
09/11/2003US20030170216 SYN3 compositions and methods
09/11/2003US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030170211 For delivering alphavirus replicon DNA into an animal or animal cells with the replicon encoding one or more heterologous genes to be expressed in the animal or the animal cells
09/11/2003US20030170210 Use of paramyxovirus vector in gene transfer into blood vessel
09/11/2003US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing
09/11/2003US20030169799 Temperature control method and apparatus for driving polymerize chain reaction (PCR) chip
09/11/2003US20030167999 Crystal
09/10/2003EP1343008A1 Supports for hybridization and method of immobilizing hybrid
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342794A1 Method and device for determination of tissue specificity of free floating DNA in bodily fluids
09/10/2003EP1342793A1 Method of screening gene expressed at desired part
09/10/2003EP1342786A2 DNA helicase
09/10/2003EP1342785A1 Gene hd3a inducing flowering of plant and utilization thereof
09/10/2003EP1342784A1 ExPEC-specific proteins, genes encoding them and uses thereof
09/10/2003EP1342783A1 An active VEGF being resistant to proteolysis
09/10/2003EP1342782A1 Method of anticipating gene network, anticipation system and recording medium
09/10/2003EP1342781A1 Recombinase fusion protein with enhanced cellular uptake
09/10/2003EP1342779A1 Means and methods for manipulating hypersensitivity-like responses
09/10/2003EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin
09/10/2003EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP
09/10/2003EP1342502A1 Particulate support for separation/purification or extraction and process for producing the same
09/10/2003EP1342477A1 Cationic vehicle: dna complexes and their use in gene therapy
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1341934A2 Improved biochip
09/10/2003EP1341932A2 Improved methods for gene expression monitoring on electronic microarrays
09/10/2003EP1341930A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
09/10/2003EP1341929A2 Fen endonucleases
09/10/2003EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
09/10/2003EP1341923A2 Methods for enhancing the efficacy of cancer therapy
09/10/2003EP1341922A2 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341919A2 Novel human kinases and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341917A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
09/10/2003EP1341916A2 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341913A2 Socs (suppressor of cytokine signaling)
09/10/2003EP1341912A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
09/10/2003EP1341911A1 Method for producing a polynucleotide library
09/10/2003EP1341910A1 Lysate clearance and nucleic acid isolation using silanized silica matrices
09/10/2003EP1341909A2 A method for in vitro molecular evolution of protein function
09/10/2003EP1341908A2 Targeted enzyme prodrug therapy
09/10/2003EP1341907A2 Target enzymes
09/10/2003EP1341906A2 Novel human kinase and polynucleotides encoding the same
09/10/2003EP1341905A2 Tec kinase assay
09/10/2003EP1341903A2 Plant derived hydroxy phenyl pyruvate dioxygneases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases
09/10/2003EP1341899A2 Bacterial host strains
09/10/2003EP1341820A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341815A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341808A2 Synthetic nucleic acid molecule compositions and methods of preparation
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341558A2 A novel system for the evaluation of the activity and/or specificity of a viral component
09/10/2003EP1341553A1 Silensed anti-cd28 antibodies and use thereof
09/10/2003EP1341414A2 Marine actinomycete taxon for drug and fermentation product discovery
09/10/2003EP1212133B1 Method and device for applying a plurality of microdroplets onto a substrate
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1075540B1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
09/10/2003EP1054689B1 Strategically modified hepatitis b core proteins and their derivatives
09/10/2003EP1023460A4 Method of isolating rna
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0954608A4 Methylation specific detection
09/10/2003EP0914613B1 Dp and e2f protein nuclear localisation signals and their use
09/10/2003EP0885237B1 Oligonucleotide analogues
09/10/2003EP0736106B1 Methods of screening for beta-amyloid peptide production inhibitors
09/10/2003EP0728198B1 Isolation of nucleic acid
09/10/2003EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441850A Cation mediated triplex hybridization assay
09/10/2003CN1441847A Recobinant plasmid PSP1, microorganisms transformed therewith, and method for producing alkaline protease VAPK
09/10/2003CN1441846A Recombinant plasmid PDSBCM, microorganisms transformed therewith, and method for producing alkaline protease VAPK
09/10/2003CN1441845A Method of detecting and quantifying human P450 molecular species and probe and kit for this method
09/10/2003CN1441844A Variable region of monoclonal antibody against HBV s-surface antigen and gene encoding same
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441842A Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441820A Method for preparing functionalised poly alkylenimides, composition containing same and uses thereof
09/10/2003CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms
09/10/2003CN1441810A Soluble CTL A4 mutant molecules and use thereof
09/10/2003CN1441809A Antifungal and/or antibacterial peptides, preparation methods and composition containing same
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
1 ... 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 ... 4023